The global pelvic floor stimulators market is set to experience significant growth over the next decade, according to a recent report by Future Market Insights (FMI). The market, valued at USD 140.39 million in 2023, is projected to expand to USD 325.41 million by 2033, reflecting a strong Compound Annual Growth Rate (CAGR) of 8.8%.
Pelvic floor stimulators are essential in managing a range of urological conditions, including cystitis, urinary retention, kidney stones, and benign prostatic hyperplasia. The increasing demand for these devices is driven by an aging population and a rising prevalence of urological disorders.
The Asia Pacific region is witnessing notable growth in demand for pelvic floor stimulators, with key markets including China, India, and Japan. This surge is attributed to a growing elderly demographic and heightened awareness of urological health issues.
“As the global population ages, there is an urgent need for effective solutions to manage urological disorders,” stated a representative from Future Market Insights. “Pelvic floor stimulators offer a non-invasive, therapeutic approach, making them increasingly popular among healthcare providers and patients alike.”
Key findings from the FMI report include:
- The global pelvic floor stimulators market is expected to reach USD 325.41 million by 2033, with a robust CAGR of 8.8%.
- Pelvic floor stimulators address the growing need for effective treatments for urological conditions such as cystitis, urinary retention, and benign prostatic hyperplasia.
- An increasing geriatric population is a major factor driving market growth, particularly in regions with high elderly population density.
- Countries like China, India, and Japan are experiencing a significant rise in demand due to a growing elderly population and increased awareness of urological issues.
Industry Innovations and Strategic Moves:
To bolster their market presence, companies are focusing on technological advancements and strategic acquisitions. Recent developments include:
- Product Launch: Zynex, a leading electrotherapy devices manufacturer, launched NeuroMove in February 2018. This product is designed to assist stroke survivors in regaining movement through neuroplasticity.
- Acquisition: Laborie, a prominent medical technology company, acquired Clinical Innovations in February 2020 for USD 525 million, aiming to strengthen its market position.
Discover the Latest Get Old Source Reports
Key Players in the Market:
- Medtronic Plc
- Atlantic Therapeutics
- Laborie Inc.
- The Prometheus Group
- Everyway Medical Instruments Co., Ltd.
- KayCo 2 Ltd.
- InControl Medical Ltd.
- Tic Medizintechnik GmbH
- Shenzhen XFT Medical Ltd.
- Chiaro Technology Ltd.
- Zynex Inc.
- Utah Medical Products, Inc.
- Verity Medical Ltd.
Market Segmentation:
- Product Type: Electrical Stimulators, Magnetic Stimulators
- Application: Urinary Incontinence, Sexual Dysfunction, Neurodegenerative Diseases
- End User: Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Homecare Settings
- Region: North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
